Methods and compositions related to thioesterase enzymes

Patent metadata

Field	Value
Publication number	US-9587231-B2
Application number	US-201514826657-A
Country	US
Kind code	B2
Filing date	Aug 14, 2015
Priority date	Dec 23, 2008
Publication date	Mar 7, 2017
Grant date	Mar 7, 2017

Abstract

The present invention relates to novel mutant thioesterase enzymes and naturally-occurring equivalents thereof, compositions made from such enzymes and uses of thioesterase enzymes. In particular, the present invention provides mutant thioesterase enzymes that have altered properties, for example, altered substrate specificity, altered activity, altered selectivity, and/or altered proportional yields in the product mixtures. The present invention also provides polynucleotides encoding such mutant thioesterase enzymes, and vectors and host cells comprising such polynucleotides. The invention further provides for novel uses of thioesterases in the production of various fatty acid derivatives, which are useful as, or as components of, industrial chemicals and fuels.

First claim

The invention claimed is:

1. A recombinant cell comprising an engineered thioesterase enzyme that converts fatty acyl substrates to fatty esters, wherein the engineered thioesterase enzyme has an amino acid sequence that is at least 90% identical to SEQ ID NO: 73 and has a substitution at an amino acid position selected from the group consisting of 13, 37, 39, 44, 47, 76, 87, 95, 104, 158, 163, and 164.

2. The recombinant cell of claim 1 , wherein the engineered thioesterase enzyme has one or more features selected from the group consisting of: (a) the amino acid residue at position 13 is isoleucine, leucine, serine, threonine, tryptophan, or tyrosine; (b) the amino acid residue at position 37 is alanine, glycine, histidine, or serine; (c) the amino acid residue at position 39 is glutamic acid, glutamine, or arginine; (d) the amino acid residue at position 44 is phenylalanine or tyrosine; (e) the amino acid residue at position 47 is phenylalanine; (f) the amino acid residue at position 76 is alanine, phenylalanine, glycine, isoleucine, methionine, asparagine, threonine, or tryptophan; (g) the amino acid residue at position 87 is methionine, serine, or tryptophan; (h) the amino acid residue at position 95 is alanine, aspartic acid, glutamic acid, leucine, or methionine; (i) the amino acid residue at position 104 is alanine, cysteine, proline, glutamine, or tryptophan; (j) the amino acid residue at position 158 is alanine, glycine, glutamine, or serine; (k) the amino acid residue at position 163 is alanine, cysteine, glutamic acid, glycine, isoleucine, methionine, serine, threonine, or valine; and (l) the amino acid residue at position 164 is cysteine.

3. The recombinant cell of claim 1 , wherein said fatty ester is a fatty acid methyl ester (FAME).

4. The recombinant cell of claim 1 , wherein said engineered thioesterase enzyme is a TesA enzyme.

5. The recombinant cell of claim 4 , wherein said TesA enzyme is derived from a bacteria selected from the group consisting of Escherichia coli, Pectobacterium atrosepticum, Photobacterium profundum, Photorhabdus luminescens, Pseudomonas putida , and Vibrio harveyi.

6. The recombinant cell of claim 1 , wherein said recombinant cell is a microbial cell.

7. The microbial cell of claim 6 , wherein said microbial cell is Escherichia coli.

8. The microbial cell of claim 6 , wherein said microbial cell is capable of spontaneously secreting or releasing said fatty ester.

9. The recombinant cell of claim 1 , wherein the cell is further engineered to exogenously express an ester synthase.

10. The recombinant cell of claim 9 , wherein said ester synthase is derived from bacteria selected from the group consisting of Marinobacter algicola DG893, Marinobacter aquaeolei VT8, and Marinobacter sp. ELB17.

11. The recombinant cell of claim 1 , wherein the cell is further engineered to exogenously express an acyl-CoA synthase (FadD).

12. A cell culture comprising the recombinant cell of claim 1 .

Assignees

• Reg Life Sciences Llc

Inventors

• Hom Louis
• Trinh Na
• Alibhai Murtaza
• Hu Zhihao
• Groban Eli
• Arlagadda Vikranth
• Clarke Elizabeth

Classifications

• C12N9/16 Primary

  acting on ester bonds (3.1) · CPC title

• C12N15/63

  Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression · CPC title

• C12N15/00

  Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (mutants or genetically engineered microorganisms, per se C12N1/00, C12N5/00, C12N7/00; new plants per se A01H; plant reproduction by tissue culture techniques A01H4/00; new animals per se A01K67/00; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy A61K48/00) · CPC title

• C10L1/02

  essentially based on components consisting of carbon, hydrogen, and oxygen only · CPC title

• C12N9/18 Primary

  Carboxylic ester hydrolases {(3.1.1)} · CPC title